Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Forget

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
European Journal of Cancer (Oxford, England : 1990)|September 29, 2001
A weekly 24-h infusion of high-dose 5-fluorouracil (5-FU)+leucovorin and bi-weekly cisplatin (CDDP) was active and well tolerated in patients with non-colon digestive carcinomasF X Caroli-Bosc, J L Van Laethem, P Michel, et al.
Science (New York, N.Y.)|February 1, 2005
Nightglow in the upper atmosphere of Mars and implications for atmospheric transportJean-Loup Bertaux, François Leblanc, Séverine Perrier, et al.
Journal of Geophysical Research. Planets|July 22, 2022
InSight Pressure Data Recalibration, and Its Application to the Study of Long-Term Pressure Changes on MarsL Lange, F Forget, D Banfield, et al.
Astrobiology|March 26, 2009
Mars environment and magnetic orbiter scientific and measurement objectivesF Leblanc, B Langlais, T Fouchet, et al.
ESMO Open|March 5, 2026
Phase II study of magrolimab combination therapies in patients with head and neck squamous-cell carcinomaA D Colevas, V Chin, J J Park, et al.
Space Science Reviews|February 15, 2021
Multi-model Meteorological and Aeolian Predictions for Mars 2020 and the Jezero Crater RegionC E Newman, M de la Torre Juárez, J Pla-García, et al.
ESMO Gastrointestinal Oncology|April 23, 2026
Phase II randomised study of magrolimab combined with bevacizumab-FOLFIRI in patients with previously treated advanced inoperable metastatic colorectal cancerM Fakih, S Gill, K Sampat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2025
Avelumab plus sacituzumab govitecan versus avelumab monotherapy as first-line maintenance treatment in patients with advanced urothelial carcinoma: JAVELIN Bladder Medley interim analysisJ Hoffman-Censits, M Tsiatas, P M-H Chang, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Efficacy and safety of short-course radiotherapy versus total neoadjuvant therapy in older rectal cancer patients: a randomised pragmatic trial (SHAPERS)R Saúde-Conde, T Vandamme, M De Backer, et al.
Icarus|September 7, 2001
The state and future of Mars polar science and explorationS M Clifford, D Crisp, D A Fisher, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|September 29, 2001
A weekly 24-h infusion of high-dose 5-fluorouracil (5-FU)+leucovorin and bi-weekly cisplatin (CDDP) was active and well tolerated in patients with non-colon digestive carcinomasF X Caroli-Bosc, J L Van Laethem, P Michel, et al.
Science (New York, N.Y.)|February 1, 2005
Nightglow in the upper atmosphere of Mars and implications for atmospheric transportJean-Loup Bertaux, François Leblanc, Séverine Perrier, et al.
Journal of Geophysical Research. Planets|July 22, 2022
InSight Pressure Data Recalibration, and Its Application to the Study of Long-Term Pressure Changes on MarsL Lange, F Forget, D Banfield, et al.
Astrobiology|March 26, 2009
Mars environment and magnetic orbiter scientific and measurement objectivesF Leblanc, B Langlais, T Fouchet, et al.
ESMO Open|March 5, 2026
Phase II study of magrolimab combination therapies in patients with head and neck squamous-cell carcinomaA D Colevas, V Chin, J J Park, et al.
Space Science Reviews|February 15, 2021
Multi-model Meteorological and Aeolian Predictions for Mars 2020 and the Jezero Crater RegionC E Newman, M de la Torre Juárez, J Pla-García, et al.
ESMO Gastrointestinal Oncology|April 23, 2026
Phase II randomised study of magrolimab combined with bevacizumab-FOLFIRI in patients with previously treated advanced inoperable metastatic colorectal cancerM Fakih, S Gill, K Sampat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2025
Avelumab plus sacituzumab govitecan versus avelumab monotherapy as first-line maintenance treatment in patients with advanced urothelial carcinoma: JAVELIN Bladder Medley interim analysisJ Hoffman-Censits, M Tsiatas, P M-H Chang, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Efficacy and safety of short-course radiotherapy versus total neoadjuvant therapy in older rectal cancer patients: a randomised pragmatic trial (SHAPERS)R Saúde-Conde, T Vandamme, M De Backer, et al.
Icarus|September 7, 2001
The state and future of Mars polar science and explorationS M Clifford, D Crisp, D A Fisher, et al.
Pageof 3